-43.0%
QXO vs GSK
-11.8%
-31.3%
-50.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.3% | -1.0% | -2.3% | -2.5% |
| 7D | -8.7% | -5.4% | -3.3% | -4.9% |
| 30D | -21.0% | -4.6% | -16.4% | -18.1% |
| 3M | -18.4% | -5.1% | -13.3% | -15.4% |
| 6M | -43.0% | -11.4% | -31.6% | -36.1% |
| All | -43.0% | -11.8% | -31.3% | -36.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling